Phase I trial of a pathotropic retroviral vector expressing a cytocidal cyclin G1 construct (Rexin-G) in patients with advanced pancreatic cancer

Evanthia Galanis, Stephanie K. Carlson, Nathan R. Foster, Val Lowe, Fernando Quevedo, Robert R. McWilliams, Axel Grothey, Aminah Jatoi, Steven R. Alberts, Joseph Rubin

Research output: Contribution to journalArticlepeer-review

29 Scopus citations

Fingerprint

Dive into the research topics of 'Phase I trial of a pathotropic retroviral vector expressing a cytocidal cyclin G1 construct (Rexin-G) in patients with advanced pancreatic cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds